
This actively managed Exchange Traded Fund (ETF) endeavors to meet its investment goals by typically allocating a minimum of 80% of its total net assets (including any capital secured through borrowing for investment purposes) into the securities of specific companies. To be eligible for inclusion, these companies must either derive at least half of their net revenue from, or commit 50% or more of their assets to, psychedelic compounds, their derivatives, or other financial instruments exhibiting similar economic characteristics. The fund's primary holdings consist of publicly traded life sciences firms focused on psychedelic medical treatments, in addition to other businesses involved in the broader psychedelics sector. It is important to note that this fund maintains a concentrated, non-diversified portfolio.
| Symbol | Name | Weight | Market Value |
|---|---|---|---|
| DFTX | Definium Therapeutics, Inc | 12.59% | $4.64M |
| CMPS | COMPASS PATHWAYS PLC | 11.14% | $4.10M |
| ATAI | ATAIBECKLEY INC | 9.06% | $3.34M |
| RLMD | RELMADA THERAPEUTICS INC | 7.03% | $2.59M |
| NRXP | NRX PHARMACEUTICALS INC | 5.92% | $2.18M |
| GHRS | GH RESEARCH PLC | 4.79% | $1.76M |
| ALKS | ALKERMES PLC | 4.74% | $1.75M |
| — | NEUROCRINE BIOSCIENCES INC | 4.52% | $1.66M |
| CYBN | CYBIN INC | 4.30% | $1.58M |
| — | ALTO NEUROSCIENCE INC | 4.27% | $1.57M |
| ABBV | ABBVIE INC | 4.24% | $1.56M |
| — | BLACKROCK TREASURY TRUST INSTL 62 | 4.16% | $1.53M |
| JNJ | JOHNSON & JOHNSON | 3.76% | $1.39M |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 3.61% | $1.33M |
| SUPN | SUPERNUS PHARMACEUTICALS INC | 3.07% | $1.13M |
| NEUP | NEUPHORIA THERAPEUTICS INC | 2.80% | $1.03M |
| — | NEURONETICS INC | 2.30% | $848.60K |
| QNTM | QUANTUM BIOPHARMA-B SUB VOT | 1.96% | $721.76K |
| KTTA | PASITHEA THERAPEUTICS CORP | 1.28% | $472.54K |
| SILO | SILO PHARMA INC | 1.16% | $426.36K |
| OPTH | OPTIMI HEALTH CORP | 1.01% | $373.75K |
| PBM | PSYENCE BIOMEDICAL LTD | 0.83% | $304.72K |
| VTGN | VISTAGEN THERAPEUTICS INC | 0.72% | $264.41K |
| IXHL | INCANNEX HEALTHCARE INC | 0.49% | $179.39K |
| NUMIF | NUMINUS WELLNESS INC | 0.46% | $169.19K |